Kolexia
Godbert Benoit Pneumologie
Godbert Benoit
Pneumologie
Hôpital Robert Schuman
Vantoux, France
106 Activités
691 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Maladies pulmonaires Carcinome pulmonaire à petites cellules Sclérodermie systémique Pneumopathies interstitielles Pneumopathie infectieuse Sclérodermie localisée Maladies auto-immunes

Collaborateurs

Voir plus
Raymond Stephane
Raymond Stephane
Hôpital Robert Schuman, Vantoux, France
Perrin Julie
Perrin Julie
Hôpital Robert Schuman, Vantoux, France
Martin Pascale
Martin Pascale
Hôpital Robert Schuman, Vantoux, France
Mercy Magalie
Mercy Magalie
Hôpital Robert Schuman, Vantoux, France

Industries

Voir plus
AstraZeneca
34 collaboration(s)
Dernière en 2023
B3TSI
11 collaboration(s)
Dernière en 2023
Boehringer Ingelheim
11 collaboration(s)
Dernière en 2023
MSD
9 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ROSIE: A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   06 mars 2024
SUNRAY-01, A Global Pivotal Study in Participants With KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Comparing First-Line Treatment of LY3537982 and Pembrolizumab vs Placebo and Pembrolizumab in Those With PD-L1 Expression ≥50% or LY3537982 and Pembrolizumab, Pemetrexed, Platinum vs Placebo and Pembrolizumab, Pemetrexed, Platinum Regardless of PD-L1 Expression
Essai Clinique (Lilly)   27 février 2024
REAL-MOOV-LUNG: Real Life Prospective Multicentric Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG
Essai Clinique (Institut Curie)   19 décembre 2023
70P LIST (Lung Initiative on Sequence Therapy): A real-world study of nivolumab for advanced NSCLC in France - First effectiveness, safety, and IO-rechallenge results
Abstract Book of the ESMO Immuno-Oncology Congress 2023 6-8 December 2023   01 décembre 2023
PROGRESSION: Pragmatic Management of Progressive Disease in Idiopathic Pulmonary Fibrosis: a Randomized Trial
Essai Clinique (Hospices Civils de Lyon)   03 août 2023
ADAPTABLE: A Non-comparative Randomized Phase II Trial Evaluating the Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced Non-squamous NSCLC Progressing After Immunotherapy and Chemotherapy
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   27 avril 2023
132P 20 years of real life nationwide epidemiological data on lung cancer in non-academic French public hospitals: KBP-2020-CPHG compared to 2000 and 2010 studies
European Lung Cancer Congress (ELCC) 2022, 30 March-2 April 2022   01 avril 2022
Bronchiolite chronique idiopathique : cohorte française rétrospective multicentrique
26e CONGRÈS DE PNEUMOLOGIE DE LANGUE FRANÇAISE   01 janvier 2022
Interstitial pneumonia with autoimmune features: Evaluation of connective tissue disease incidence during follow-up.
European journal of internal medicine   23 décembre 2021
Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study.
European journal of cancer (Oxford, England : 1990)   19 novembre 2021